Get the Stockscreener App
1.29
3.73%
-0.05
60 Degrees Pharmaceuticals Inc stock is traded at $1.29, with a volume of 22,248.
It is down -3.73% in the last 24 hours and down -9.15% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$1.34
Open:
$1.31
24h Volume:
22,248
Relative Volume:
0.16
Market Cap:
$5.41M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.1294
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
-9.15%
1M Performance:
-9.15%
6M Performance:
-43.42%
1Y Performance:
-71.04%
1-Day Range:
$1.30
$1.3255
1-Week Range:
$1.2998
$1.45
52-Week Range:
$1.215
$12.45
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.3171 | 5.50M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.49 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.97 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
838.79 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.66 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
How to integrate 60 Degrees Pharmaceuticals Inc. Equity Warrant into portfolio analysis tools - newser.com
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant see short term momentumLong Setup & Entry Point Confirmation Signals - newser.com
Can momentum traders help lift 60 Degrees Pharmaceuticals Inc.Weekly Trade Analysis & Safe Entry Point Identification - newser.com
Using data models to predict 60 Degrees Pharmaceuticals Inc. stock movementPortfolio Gains Summary & Daily Price Action Insights - newser.com
Why 60 Degrees Pharmaceuticals Inc. stock is popular among millennialsPortfolio Value Report & Safe Entry Trade Signal Reports - newser.com
How to forecast 60 Degrees Pharmaceuticals Inc. trends using time series2025 Biggest Moves & AI Forecast for Swing Trade Picks - newser.com
News impact scoring models applied to 60 Degrees Pharmaceuticals Inc.Weekly Loss Report & Free Growth Oriented Trading Recommendations - newser.com
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain operating marginsJuly 2025 Summary & Daily Technical Stock Forecast Reports - newser.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock affected by interest rate hikesWeekly Risk Summary & Weekly Watchlist for Consistent Profits - newser.com
Published on: 2025-11-03 05:37:50 - newser.com
How geopolitical tensions affect 60 Degrees Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Reactions & Safe Capital Growth Plans - newser.com
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock could benefit from AI revolutionBreakout Watch & Daily Chart Pattern Signal Reports - newser.com
How to use a screener to detect 60 Degrees Pharmaceuticals Inc. Equity Warrant breakoutsOptions Play & Daily Profit Focused Stock Screening - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervaluedTreasury Yields & Real-Time Stock Entry Alerts - newser.com
Institutional scanner results for 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Intraday Action & Daily Chart Pattern Signals - newser.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock attractive for hedge fundsJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock resist market sell offsTrade Analysis Report & Expert-Curated Trade Recommendations - newser.com
60 Degrees Pharmaceuticals Inc. Equity Warrant stock daily chart insightsJuly 2025 Trends & AI Powered Trade Plan Recommendations - newser.com
Developing predictive dashboards with 60 Degrees Pharmaceuticals Inc. Equity Warrant data - newser.com
What’s next for 60 Degrees Pharmaceuticals Inc. Equity Warrant stock priceWall Street Watch & Daily Profit Focused Screening - newser.com
Forecasting 60 Degrees Pharmaceuticals Inc. Equity Warrant price range with options dataCPI Data & Long-Term Growth Plans - newser.com
Using AI based signals to follow 60 Degrees Pharmaceuticals Inc.Trade Volume Summary & Accurate Trade Setup Notifications - newser.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock attractive for growth ETFs2025 Major Catalysts & Verified Momentum Stock Alerts - newser.com
Real time alert setup for 60 Degrees Pharmaceuticals Inc. performanceMarket Sentiment Report & Reliable Price Action Trade Plans - newser.com
Why analysts upgrade 60 Degrees Pharmaceuticals Inc. stockJuly 2025 Levels & Expert Verified Movement Alerts - newser.com
Has 60 Degrees Pharmaceuticals Inc. Equity Warrant formed a bullish divergenceTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Chart based analysis of 60 Degrees Pharmaceuticals Inc. Equity Warrant trendsWeekly Market Outlook & Intraday High Probability Setup Alerts - newser.com
Will 60 Degrees Pharmaceuticals Inc. stock attract more institutional investorsWeekly Stock Analysis & Weekly Setup with High ROI Potential - newser.com
How strong is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock revenue growthWeekly Trade Report & Safe Capital Growth Trade Ideas - newser.com
Predicting 60 Degrees Pharmaceuticals Inc. Equity Warrant trend using moving averagesJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - newser.com
60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
What machine learning models say about 60 Degrees Pharmaceuticals Inc.Quarterly Earnings Report & Reliable Volume Spike Trade Alerts - newser.com
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
1.11%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):